A mini-review of CD13 antigen in AML : Easy induction or enhancement of expression in in vitro culture and necessary consideration for assessment

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 33, Issue SUPPL.2, 2002, Pages 155-157

  Tatsumi, Eiji ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; MICROSOMAL AMINOPEPTIDASE; MONOCLONAL ANTIBODY;

CELL CULTURE; HUMAN; IMMUNOLOGY; IN VITRO STUDY; MYELOID LEUKEMIA; REVIEW;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD13; HUMANS; LEUKEMIA, MYELOID; TUMOR CELLS, CULTURED;

EID: 11244309044     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Arber DA. Glackin C, Lowe G, et al. Presence of t(8;21) (q22;q22)in myeloperoxidase-positive, myeloid surface antigen-negative acute myeloid leukemia. Am J Clin Pathol 1997; 107: 68-73.
2. Ashmun RA, Look TA Metalloproteinase activity of CD13/aminopeptidase N on the surface of human myeloid cells. Blood 1990; 75: 462-9.
3. Delmas B, Geefi J, L'Haridon R. et al. Aminopeptidase N is a major receptor for the enteropathogenic cornavirus TGEV. Nature 1992; 357: 417-20.
4. Dybkaer K, Olesen G, Pedersen FS, Kristensen JS. Stro-mal-mediated down-regulation of CD 13 in bone marrow cells originating from acute myeloid leukemia patients. Eur J Hematol 2001; 66: 168-77.
5. Griffin JD, Ritz J, Nadler LM, Sclossman SF. Expression of myeloid differentiation antiegns on normal and mahganat myeloid cells. J Clin Invest 1981; 68: 932-41.
6. Hara J, Kawa-Ha K, Yumura-Yagi K, et al. In vitro and in vitro expression of myeloid antigens on B-lineage acute lymphoblastic leukemia cells. Leukemia 1991; 5: 19-25.
7. Kawano S, Tatsumi E, Yoneda N, Yamaguchi N. CD45 RA/RO isoformic antigens in acute myeloblastic (AML) leukemia cells. Am J Clin Pathol 1993; 100: 386-93.
8. Kraguljac N, Marisavljevic D, Jankovic G, et al. Characterization of CD 13 and CD33 surface antigen-negative acute myeloid leukemia. Am J Clin Pathol 2000; 114: 29-34.
9. Nakajima M, Chop AM. Tumor invasion and extracellular matrix degradative enzyme- regulation of activity by organ factors. Semin Cancer Biol 1991; 2: 115-27.
10. Saiki I, Fujii H, Yoneda J, et al. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer 1993; 54: 137-43.
11. Saito M, Kumagai M, Okazaki T, et al. Stromal cell-mediated transcriptional regulation of the CD13/aminopeptidase N gene in leukemic cells. Leukemia 1995; 9: 1508-16.
12. Seshi B, Kashyap A, Bennet JM. Acute myeloid leukemia with an unusual phenotype: myeloperoxidase(+), CD13(-), CD14(-) and CD33(-). Br J Haematol 1992; 81: 374-7.
13. Solbach W. Tumor-promoting phorbol ester selectively abrogates the expression of the T4 differentiation antigen expressed on normal and malignant (Sezary) T helper lymphocytes. J Exp Med 1982; 156: 1250-5.
14. Takatsuki K, Hirouchi W, Tatsumi E, Yoneda N, Yamaguchi N. The absence of monocyte-granulocyte antigen expression in a case of AML. Jpn J Clin Hematol 1991; 32: 167-9, (English Abstract)
15. Tatsumi E, Sagawa K, Sugimoto T, Minowada J. Immunological membrane phenotypes in human myeloid leukemia by monoclonal antibodies. Proc Am Assoc Cancer Res 1981; 22 (suppl): 181 A.
16. Tatsumi E, Piontek C, Sugimoto T, Minato K, Minowada J. Selective loss of the expression of OKT-4 or Leu-3A defined antigen by 12-o-tetradecanoyl phorbol-13-acetate (TPA) in human lymphoid cell. Am J Hematol 1984; 17: 287-94.
17. Look TA, Ashmun RA, Shapiro LH, Peiper SC. Human myeloid plasma membrane glycoprotein CD 13 (gp150) is identical to aminopeptidase N. J Clin Invest 1989;83:1299-307.
18. Yeager CL, Ashmun RA, William RK, et al. Human aminopeptidase N is a receptor for human cornavirus 229E. Nature 1992; 357: 420-2.
19. Yoneda N, Tatsumi E, Teshigawara K. et al. Lineage determination of CD7+ CD5- CD2- and CD7+ CD5+ CD2- lymphoblasts : Studies on phenotype, genotype and gene expression of myelo-peroxidase (MPO), CD3ε and CD3σ chains. Am J Hematol 1994; 45: 310-20.